Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “asthma”

Combination of High-flow Nasal Oxygen (Optiflow) and Vibrating Membrane Nebuliser (Aerogen) in the Pre-hospital Setting - Before/After StudyWithdrawn
NCT07791992N/AUpdated Aug 28, 2026
Sponsor: Centre Hospitalier Sud Francilien
Hypercapnia · Asthma Exacerbation · COPD Exacerbation
France
Asthma Lung Sounds With Wearable StethoscopeNot Yet Recruiting
NCT07792330NAUpdated Aug 28, 2026
Sponsor: Children's Hospital Los Angeles
Asthma · Pediatric Asthma · Airway Obstruction Upper
United States
Longitudinal Observational Study of Severe AsthmaCompleted
NCT01780142N/AUpdated Aug 27, 2026
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Asthma
United States
A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With AsthmaRecruiting
NCT07525375Phase 2Updated Aug 27, 2026
Sponsor: AstraZeneca
Asthma
United States, Argentina, Czechia, Hungary, Mexico +2 more
Rademikibart IV for Acute Asthma and COPD ExacerbationRecruiting
NCT07705737Phase 2Updated Aug 27, 2026
Sponsor: Connect Biopharm LLC
Asthma Acute · COPD Exacerbation Acute
United States
A Phase 1 Trial of AMG 691 in Healthy Chinese and Japanese VolunteersRecruiting
NCT07745907Phase 1Updated Aug 27, 2026
Sponsor: Amgen
Healthy Participants
United States
Budesonide/Formoterol Inhalation Powder in Adults With AsthmaCompleted
NCT07790159Phase 3Updated Aug 27, 2026
Sponsor: Shanghai Xin Huanghe Pharmaceutical Co., Ltd.
Asthma
China
Family-centred Pulmonary Rehabilitation to Empower CarersNot Yet Recruiting
NCT07791147NAUpdated Aug 27, 2026
Sponsor: Aveiro University
Pulmonary Disease, Chronic Obstructive · Lung Diseases, Interstitial · Asthma · Lung Neoplasms
Portugal
A Study Evaluating the Effect of Inhaled PT007(AS MDI) Versus Placebo MDI and Ventolin Evohaler on Lung Function in Adult Participants With AsthmaCompleted
NCT06644924Phase 2Updated Aug 27, 2026
Sponsor: AstraZeneca
Asthma
United States
Expression of TSLP Isoforms in AsthmaRecruiting
NCT07786870N/AUpdated Aug 26, 2026
Sponsor: Medical University of Warsaw
Asthma Atopic · Asthma Severe Persistent Uncontrolled
Poland
Withania Somnifera for Moderate-to-Severe Persistent AsthmaCompleted
NCT07787507NAUpdated Aug 26, 2026
Sponsor: Aligarh Muslim University
Asthma
India
This Study Aims to Compare Asthma Control in Children Monitored With FeNO Against a Historical Cohort Without FeNO. Secondary Objectives Include Evaluating Associations Between FeNO Levels, ACT/C-ACT Scores, Eosinophil Counts, FEV1%, ICS Adherence, and Exacerbation Frequency.Recruiting
NCT07788534NAUpdated Aug 26, 2026
Sponsor: King Faisal Specialist Hospital & Research Center
Asthma Childhood
Saudi Arabia
A Study of Depemokimab in Participants of 6 to 11 Years of AgeRecruiting
NCT07671001Phase 3Updated Aug 26, 2026
Sponsor: GlaxoSmithKline
Asthma
United States
QUARTZ: Comparative Effectiveness of Switching From Albuterol to Albuterol/Budesonide Versus Adding Low-dose ICS or LTRA to AlbuterolNot Yet Recruiting
NCT07787117N/AUpdated Aug 26, 2026
Sponsor: AstraZeneca
Asthma
A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.Recruiting
NCT05776927Phase 3Updated Aug 26, 2026
Sponsor: Novartis Pharmaceuticals
Asthma
Poland, South Africa
Self-Management Of Asthma By Forced Oscillation TechniqueTerminated
NCT04963140NAUpdated Aug 26, 2026
Sponsor: Restech Srl
Asthma
Australia, France, Italy
Benralizumab Airway Remodeling Study in Severe Eosinophilic AsthmaticsActive Not Recruiting
NCT03953300Phase 4Updated Aug 25, 2026
Sponsor: AstraZeneca
Asthma
United States, Canada, Denmark, Sweden, United Kingdom
A Study to Investigate the Efficacy and Safety of GSK5784283 Compared With Placebo in Participants With Uncontrolled Asthma (PERSIST ASTHMA-2)Not Yet Recruiting
NCT07782996Phase 3Updated Aug 24, 2026
Sponsor: GlaxoSmithKline
Asthma
A Study to Investigate the Efficacy and Safety of GSK5784283 Compared With Placebo in Participants With Uncontrolled Asthma (PERSIST ASTHMA-1)Not Yet Recruiting
NCT07780643Phase 3Updated Aug 21, 2026
Sponsor: GlaxoSmithKline
Asthma
A Study to Assess the Potential for Airway Sensitivity Reactions With Propellants HFA-152a (Test) and HFA-134a (Reference) Administered Via Pressurized Inhalers in Adults With Mild AsthmaCompleted
NCT06702462Phase 1Updated Aug 21, 2026
Sponsor: GlaxoSmithKline
Asthma
United States
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe AsthmaRecruiting
NCT07219173Phase 2Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Asthma
United States, Argentina, Brazil, Canada, China +7 more
Tezepelumab PRO StudyCompleted
NCT05922891N/AUpdated Aug 21, 2026
Sponsor: AstraZeneca
Asthma
Japan
Registry of Asthma Characterization and Recruitment 3 (RACR3)Recruiting
NCT05272241N/AUpdated Aug 21, 2026
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Asthma
United States
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting
NCT04278404N/AUpdated Aug 21, 2026
Sponsor: Duke University
Coronavirus Infection (COVID-19) · Pulmonary Arterial Hypertension · Urinary Tract Infections in Children · Hypertension
United States, Canada
Creation of a Biological Collection of BRonchiaI and Pulmonary Tissues From Surgical wastENot Yet Recruiting
NCT07780630N/AUpdated Aug 21, 2026
Sponsor: University Hospital, Bordeaux
COPD (Chronic Obstructive Pulmonary Disease) · Asthma (Diagnosis) · Safe Volunteers
France

Previous page Next page